Sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes in North India: A 12-month prospective study in real-world setting
Author:
Affiliation:
1. Fortis C-DOC Hospital for Diabetes; Metabolic Diseases and Endocrinology; New Delhi India
2. National Diabetes, Obesity and Cholesterol Foundation; New Delhi India
Publisher
Hindawi Limited
Subject
General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ijcp.13237/fullpdf
Reference27 articles.
1. International Diabetes Federation IDF Diabetes Atlas Brussels, Belgium International Diabetes Federation 2017
2. Diabetes, cardiovascular disease, and chronic kidney disease in South Asia: current status and future directions;Misra;BMJ,2017
3. Body fat patterning, hepatic fat and pancreatic volume of non-obese asian indians with type 2 diabetes in North India: a case-control study;Misra;PLoS ONE,2015
4. Epidemiology of macrovascular complications of diabetes in South Asians and comparison with other ethnicities;Gupta;Int Cardiovasc Forum J,2016
5. India Diabetes Management Algorithm Proposal Group Diabetes Technology & Therapeutics 2016 18 346 350 https://doi.org/10.1089/dia.2015.0308
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Metabolic and renal outcomes of empagliflozin in patients with type 2 diabetes mellitus attending Armed Forces Hospital in Saudi Arabia;Saudi Medical Journal;2023-07
2. Risk Amplifiers for Vascular Disease and CKD in South Asians;Clinical Journal of the American Society of Nephrology;2023-01-20
3. Prevalence of Bacterial Urinary Tract Infection Among Patients With Type 2 Diabetes Mellitus on Sodium-Glucose Cotransporter-2 Inhibitors: A Prospective Real-World Setting Study;Journal of the ASEAN Federation of Endocrine Societies;2022-11-25
4. Clinical outcomes of Sodium-glucose cotransporter-2 inhibitors in patients with Type 2 Diabetes Mellitus: An observational study from Pakistan;Pakistan Journal of Medical Sciences;2021-07-15
5. SGLT 2 Inhibitors; glycemic control, weight loss and safety profile in patients with type 2 Diabetes, at Medicell Institute (MIDEM);Pakistan Journal of Medical Sciences;2020-12-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3